Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial

Physiotherapy. 2016 Dec;102(4):357-364. doi: 10.1016/j.physio.2015.07.005. Epub 2015 Dec 1.

Abstract

Objective: To compare the efficacy of three slow expiratory airway clearance techniques (ACTs).

Design: Randomised crossover trial.

Setting: Tertiary hospital.

Participants: Thirty-one outpatients with bronchiectasis and chronic sputum expectoration.

Interventions: Autogenic drainage (AD), slow expiration with glottis opened in lateral posture (ELTGOL), and temporary positive expiratory pressure (TPEP).

Main outcomes: Sputum expectoration during each session (primary endpoint) and in the 24-hour period after each session. Leicester Cough Questionnaire (LCQ) score and spirometry results were recorded at the beginning and after each week of treatment. Data were summarised as median difference [95% confidence interval (CI)].

Results: Median (interquartile range) daily expectoration at baseline was 21.1 (15.3 to 35.6)g. During physiotherapy sessions, AD and ELTGOL expectorated more sputum than TPEP [AD vs TPEP 3.1g (95% CI 1.5 to 4.8); ELTGOL vs TPEP 3.6g (95% CI 2.8 to 7.1)], while overall expectoration in the 24-hour period after each session was similar for all techniques (P=0.8). Sputum clearance at 24hours post-intervention was lower than baseline assessment for all techniques [AD vs baseline -10.0g (95% CI -15.0 to -6.8); ELTGOL vs baseline -9.2g (95% CI -14.2 to -7.9); TPEP vs baseline -6.0g (95% CI -12.0 to -6.1)]. The LCQ score increased with all techniques (AD 0.5, 95% CI 0.1 to 0.5; ELTGOL 0.9, 95% CI 0.5 to 2.1; TPEP 0.4, 95% CI 0.1 to 1.2), being similar for all ACTs (P=0.6). No changes in lung function were observed.

Conclusions: Slow expiratory ACTs enhance mucus clearance during treatment sessions, and reduce expectoration for the rest of the day in patients with bronchiectasis.

Clinical trial registration number: NCT01854788.

Keywords: Bronchiectasis; Crossover studies; Mucus; Quality of life; Respiratory therapy.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bronchiectasis / rehabilitation*
  • Cough
  • Cross-Over Studies
  • Drainage, Postural / methods
  • Exhalation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Preference
  • Respiratory Function Tests
  • Respiratory Therapy / methods*
  • Sputum
  • Tertiary Care Centers

Associated data

  • ClinicalTrials.gov/NCT01854788